• SALIX PHARMACEUTICALS INC Analyst Recommendations

  • Analyst Consensus: SLXP

    First Call Consensus Recommendation

    • Strong Buy1
    • Buy2
    • Hold3
    • Sell4
    • Strong Sell5
    Mean Analyst Consensus Recommendation Analysts Reporting
    Current Recommendation 3.000 Hold 7
    30 Days Ago 3.000 Hold 8
    60 Days Ago 2.875 Hold 8
    90 Days Ago 2.875 Hold 8
    120 Days Ago 2.875 Hold 8

  • Analyst Ratings: SLXP

    Brokerage Firm Previous Rating Current Rating Change Date Price Target
    Roth Capital Buy Hold 08/05/2008 8.00
    Roth Capital — Buy 03/04/2008 8.25
    Credit Suisse — Neutral 02/28/2008 7.00
    Friedman Billings Mkt Perform — 02/08/2008 —
    Roth Capital — Buy 02/01/2008 11.00
    Friedman Billings — Mkt Perform 02/01/2008 7.50
    Roth Capital — Buy 12/31/2007 13.50
    Piper Jaffray Neutral Sell 12/31/2007 —
    Friedman Billings — Mkt Perform 12/31/2007 8.50
    Roth Capital — Buy 09/06/2007 17.00
    Roth Capital — Buy 05/09/2007 16.00
    Susquehanna Financial — Neutral 10/19/2006 —
    Roth Capital — Buy 07/20/2006 17.00
    BMO Nesbitt Burns — Market Perform 07/11/2006 13.00
    William Blair Outperform Mkt Perform 02/27/2006 —
    Sun Trust Rbsn Humphrey Neutral Buy 06/06/2005 22.50
    Piper Jaffray — Market Perform 01/21/2005 21.00
    Roth Capital Buy Strong Buy 01/06/2005 27.00
    Sun Trust Rbsn Humphrey Buy Neutral 11/18/2004 —
    Roth Capital — Buy 08/10/2004 26.67
    Roth Capital Strong Buy Buy 07/02/2004 40.00
    CE Unterberg Towbin Market Perform Buy 06/17/2004 40.00
    Roth Capital Buy Strong Buy 06/07/2004 —
    Wells Fargo Sec Buy Hold 05/26/2004 —
    CE Unterberg Towbin — Market Perform 05/25/2004 —
    Roth Capital — Buy 05/17/2004 38.00
    Wells Fargo Sec — Buy 04/26/2004 —
    Wells Fargo Sec — Buy 02/20/2004 36.00
    Wachovia Outperform Mkt Perform 02/13/2004 —
    Roth Capital Strong Buy Buy 02/04/2004 32.50
    Next